Pixee Medical
Private Company
Total funding raised: $6.5M
Overview
Pixee Medical is a commercial-stage medical device company pioneering an ultra-compact, headset-based augmented reality navigation platform for orthopedic surgery. Its FDA-approved Knee+ NexSight system for total knee arthroplasty represents a significant innovation, offering surgeon-controlled guidance with high precision in a portable, cost-effective format suitable for outpatient surgical centers. The company has established a global presence, with its technology trusted by multiple healthcare institutions, and is actively developing next-generation AR solutions for the knee and potentially other orthopedic applications. Backed by strategic partnerships and a growing patent portfolio, Pixee is positioned to capitalize on the shift towards value-based, ambulatory joint replacement surgery.
Technology Platform
Ultra-compact, headset-based Augmented Reality (AR) surgical navigation platform combined with high-precision instruments and planning software. Designed for surgeon-controlled guidance with minimal OR footprint and no bulky capital equipment.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Pixee competes in the computer-assisted orthopedic surgery market, which is dominated by large-cap players like Stryker (Mako), Zimmer Biomet (ROSA), and Johnson & Johnson (Velys) offering robotic-assisted surgery systems. It also competes with other optical and electromagnetic navigation systems, as well as patient-specific instrumentation (PSI) companies. Pixee's key differentiation is its ultra-portable, AR-based, surgeon-worn system that aims to deliver navigation-level precision at a lower total cost.